Barrington Research Reaffirms "Outperform" Rating for Adtalem Global Education (NYSE:CVSA)

Key Points

• Barrington Research reaffirmed an "Outperform" rating on Adtalem with a $170 price target, implying about a 43.3% upside from the recent close.
• Analyst coverage is mixed but positive overall — two Buy and two Hold ratings yield a MarketBeat consensus of a "Moderate Buy" and a $150 consensus target price.
• Insiders have been buying: Director Michael W. Malafronte purchased 15,305 shares (~$1.54M) and insiders acquired 37,236 shares (~$3.75M) in the past three months; insiders now own about 2.5% of the stock.

Adtalem Global Education (NYSE:CVSA - Get Free Report)'s stock had its "outperform" rating reaffirmed by equities research analysts at Barrington Research in a research note issued to investors on Friday,Benzinga reports. They currently have a $170.00 target price on the stock. Barrington Research's price objective would indicate a potential upside of 43.33% from the company's previous close.

CVSA has been the subject of a number of other reports. Weiss Ratings started coverage on shares of Adtalem Global Education in a research note on Wednesday, February 25th. They issued a "hold (c+)" rating for the company. Zacks Research cut shares of Adtalem Global Education from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, March 25th. Finally, Truist Financial started coverage on shares of Adtalem Global Education in a research note on Tuesday, March 24th. They issued a "buy" rating and a $130.00 price objective for the company. Two equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company's stock. According to MarketBeat.com, Adtalem Global Education presently has a consensus rating of "Moderate Buy" and a consensus target price of $150.00.

Adtalem Global Education Stock Performance

Shares of NYSE CVSA traded up $2.61 during midday trading on Friday, reaching $118.61. The stock had a trading volume of 89,523 shares, compared to its average volume of 405,127. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.68 and a quick ratio of 0.68. The stock has a market cap of $4.09 billion, a PE ratio of 17.40, a price-to-earnings-growth ratio of 0.95 and a beta of 0.63. Adtalem Global Education has a 12-month low of $86.97 and a 12-month high of $156.26.

Adtalem Global Education (NYSE:CVSA - Get Free Report) last announced its quarterly earnings data on Wednesday, January 28th. The company reported $2.43 earnings per share (EPS) for the quarter. The firm had revenue of $503.39 million during the quarter. Adtalem Global Education had a net margin of 13.41% and a return on equity of 20.24%.

Insider Buying and Selling at Adtalem Global Education

In related news, Director Michael W. Malafronte bought 15,305 shares of the company's stock in a transaction that occurred on Tuesday, March 10th. The stock was purchased at an average price of $100.86 per share, for a total transaction of $1,543,662.30. Following the completion of the transaction, the director owned 16,505 shares in the company, valued at $1,664,694.30. The trade was a 1,275.42% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders have acquired a total of 37,236 shares of company stock worth $3,752,866 in the last three months. 2.50% of the stock is currently owned by corporate insiders.

About Adtalem Global Education

Adtalem Global Education NYSE: CVSA is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.